Italeaf SpA operates in the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Italeaf SpA with three other
financial institutions in Europe:
sales of 762.70 million Swedish Kronor [US$90.75 million]
of which 100%
was Investment Activities),
MedCap AB (publ)
(816.92 million Swedish Kronor [US$97.21 million]
of which 74%
was Unimedic), and
DeA Capital S.p.A.
(79.29 million Euro [US$98.14 million]
Sales fell dramatically in 2016:
Italeaf SpA reported sales of 70.17 million Euro (US$86.85 million)
December of 2016.
decrease of 80.7%
versus 2015, when the company's sales were 364.08 million Euro.